PT Metro Healthcare Indonesia Tbk Statistics
PT Metro Healthcare Indonesia Tbk (CARE) Stock Statistics & Valuation Metrics
Total Valuation
PT Metro Healthcare Indonesia Tbk has a market cap or net worth of IDR 12.44T. The enterprise value is IDR 12.21T.
- Market Cap
- IDR 12.44T
- Enterprise Value
- IDR 12.21T
Share Statistics
PT Metro Healthcare Indonesia Tbk has 33,250,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 33,250,000,000
- Owned by Insiders
- ―
- Owned by Institutions
- 0.09%
Financial Efficiency
PT Metro Healthcare Indonesia Tbk’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 1.09%.
- Return on Equity (ROE)
- 0.00
- Return on Assets (ROA)
- 0.00
- Return on Invested Capital (ROIC)
- 1.09%
- Return on Capital Employed (ROCE)
- 0.02
- Revenue Per Employee
- 518.58M
- Profits Per Employee
- 5.84M
- Employee Count
- 848
- Asset Turnover
- 0.11
- Inventory Turnover
- 42.02
Valuation Ratios
The current PE Ratio of PT Metro Healthcare Indonesia Tbk is 1752.68. PT Metro Healthcare Indonesia Tbk’s PEG ratio is 6.72.
- PE Ratio
- 1752.68
- PS Ratio
- 20.96
- PB Ratio
- 3.96
- Price to FCF
- -64.45
- Price to Operating Cash Flow
- 399.57
- PEG Ratio
- 6.72
Income Statement
In the last 12 months, PT Metro Healthcare Indonesia Tbk had revenue of 439.75B and earned 4.95B in profits. Earnings per share was 0.15.
- Revenue
- 439.75B
- Gross Profit
- 215.16B
- Operating Income
- 70.52B
- Pretax Income
- 8.07B
- Net Income
- 4.95B
- EBITDA
- 96.84B
- Earnings Per Share (EPS)
- 0.15
Cash Flow
In the last 12 months, operating cash flow was 29.96B and capital expenditures -215.69B, giving a free cash flow of -185.73B billion.
- Operating Cash Flow
- 29.96B
- Free Cash Flow
- -185.73B
- Free Cash Flow per Share
- -5.59
Dividends & Yields
PT Metro Healthcare Indonesia Tbk pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.55%
- Earnings Yield
- 0.06%
Stock Price Statistics
- Beta
- 0.83
- 52-Week Price Change
- 14.02%
- 50-Day Moving Average
- 381.36
- 200-Day Moving Average
- 412.56
- Relative Strength Index (RSI)
- 53.45
- Average Volume (3m)
- 42.93M
Important Dates
PT Metro Healthcare Indonesia Tbk upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 30, 2026
- Next Earnings Date
- Apr 01, 2027
- Ex-Dividend Date
- ―
Financial Position
PT Metro Healthcare Indonesia Tbk as a current ratio of 0.84, with Debt / Equity ratio of 27.59%
- Current Ratio
- 0.84
- Quick Ratio
- 0.83
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- 4.27
- Interest Coverage Ratio
- 0.88
Taxes
In the past 12 months, PT Metro Healthcare Indonesia Tbk has paid 2.93B in taxes.
- Income Tax
- 2.93B
- Effective Tax Rate
- 0.36
Enterprise Valuation
PT Metro Healthcare Indonesia Tbk EV to EBITDA ratio is 91.46, with an EV/FCF ratio of -67.95.
- EV to Sales
- 22.10
- EV to EBITDA
- 91.46
- EV to Free Cash Flow
- -67.95
- EV to Operating Cash Flow
- 421.31
Balance Sheet
PT Metro Healthcare Indonesia Tbk has IDR 961.66B in cash and marketable securities with IDR 1.55T in debt, giving a net cash position of -IDR 589.72B billion.
- Cash & Marketable Securities
- IDR 961.66B
- Total Debt
- IDR 1.55T
- Net Cash
- -IDR 589.72B
- Net Cash Per Share
- -IDR 17.74
- Tangible Book Value Per Share
- IDR 91.08
Margins
Gross margin is 46.72%, with operating margin of 20.04%, and net profit margin of 1.20%.
- Gross Margin
- 46.72%
- Operating Margin
- 20.04%
- Pretax Margin
- 2.05%
- Net Profit Margin
- 1.20%
- EBITDA Margin
- 24.17%
- EBIT Margin
- 20.29%
Analyst Forecast
The average price target for PT Metro Healthcare Indonesia Tbk is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 80.77%
- EPS Growth Forecast
- ―
